Stage IV Oropharyngeal (p16-Negative) Carcinoma AJCC v8

18 clinical trials · Condition

Record	Firm	Date
Testing the Addition of an Anti-cancer Drug, Ipatasertib, to the Usual Immunotherapy Treatment (Pembrolizumab) in Patients With Recurrent or Metastatic Squamous Cell Cancer of the Head and Neck (NCT05172258)	National Cancer Institute (NCI)	2022-07-26
Testing the Addition of an Anti-cancer Drug, BAY 1895344, With Radiation Therapy to the Usual Pembrolizumab Treatment for Recurrent Head and Neck Cancer (NCT04576091)	National Cancer Institute (NCI)	2022-07-06
Comparing Cisplatin Every Three Weeks to Cisplatin Weekly When Combined With Radiation for Patients With Advanced Head and Neck Cancer (NCT05050162)	NRG Oncology	2022-02-01
Surgery Vs Chemoradiation for Oropharyngeal Cancer- A Phase II/III Integrated Design Randomized Control Trial (NCT05144100)	Tata Memorial Centre	2021-12-01
Sodium Thiosulfate in Preventing Ototoxicity for Squamous Cell Cancer Patients Undergoing Chemoradiation With Cisplatin (NCT04541355)	Hyunseok Kang, MD	2020-10-14
Celecoxib Through Surgery and Radiation Therapy for the Treatment of Advanced Head and Neck Cancer (NCT04162873)	University of Utah	2019-11-27
Oropharynx (OPX) Biomarker Trial (NCT06356272)	Mayo Clinic	2019-11-15
Blood Tests and Questionnaires in Studying Adherence to Preventative Swallowing Exercises in Participants With Metastatic Head and Neck Cancer (NCT03010150)	M.D. Anderson Cancer Center	2016-12-29

Every clearance here is in the API, with alerts when new ones post.